Pathology and pathogenesis of craniopharyngiomas SJ Larkin, O Ansorge Pituitary 16 (1), 9, 2013 | 144 | 2013 |
Noninvasive quantification of 2-hydroxyglutarate in human gliomas with IDH1 and IDH2 mutations UE Emir, SJ Larkin, N de Pennington, N Voets, P Plaha, R Stacey, ... Cancer research 76 (1), 43-49, 2016 | 131 | 2016 |
Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas OA Sarah Larkin, Raghava Reddy, Niki Karavitaki, Simon Cudlip, John Wass European Journal of Endocrinology 168, 491, 2013 | 129 | 2013 |
Imidazopurinones are markers of physiological genomic damage linked to DNA instability and glyoxalase 1-associated tumour multidrug resistance PJ Thornalley, S Waris, T Fleming, T Santarius, SJ Larkin, ... Nucleic acids research 38 (16), 5432-5442, 2010 | 125 | 2010 |
Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study D Iacovazzo, R Caswell, B Bunce, S Jose, B Yuan, ... Acta neuropathologica communications 4, 1-12, 2016 | 116 | 2016 |
BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma SJ Larkin, V Preda, N Karavitaki, A Grossman, O Ansorge Acta Neuropathologica 127 (6), 927, 2014 | 111 | 2014 |
Rathke's cleft cyst S Larkin, N Karavitaki, O Ansorge Handbook of clinical neurology 124, 255-269, 2014 | 66 | 2014 |
Development and microscopic anatomy of the pituitary gland S Larkin, O Ansorge | 61 | 2017 |
Reversal of hyperglycemia‐induced angiogenesis deficit of human endothelial cells by overexpression of glyoxalase 1 in vitro U Ahmed, D Dobler, SJ Larkin, N Rabbani, PJ Thornalley Annals of the New York Academy of Sciences 1126 (1), 262-264, 2008 | 57 | 2008 |
Oncolytic herpesvirus expressing PD-L1 BiTE for cancer therapy: exploiting tumor immune suppression as an opportunity for targeted immunotherapy H Khalique, R Baugh, A Dyer, EM Scott, S Frost, S Larkin, ... Journal for immunotherapy of cancer 9 (4), 2021 | 40 | 2021 |
Improved localization for 2-hydroxyglutarate detection at 3 T using long-TE semi-LASER A Berrington, NL Voets, P Plaha, SJ Larkin, J Mccullagh, R Stacey, ... Tomography 2 (2), 94-105, 2016 | 33 | 2016 |
The Wnt signalling cascade and the adherens junction complex in craniopharyngioma tumorigenesis V Preda, SJ Larkin, N Karavitaki, O Ansorge, AB Grossman Endocrine pathology 26, 1-8, 2015 | 33 | 2015 |
A comparison of 2‐hydroxyglutarate detection at 3 and 7 T with long‐TE semi‐LASER A Berrington, NL Voets, SJ Larkin, N de Pennington, J Mccullagh, ... NMR in Biomedicine 31 (3), e3886, 2018 | 30 | 2018 |
Pathology and pathogenesis of pituitary adenomas and other sellar lesions S Larkin, O Ansorge Endotext [Internet], 2017 | 30 | 2017 |
A noninvasive comparison study between human gliomas with IDH1 and IDH2 mutations by MR spectroscopy X Shen, NL Voets, SJ Larkin, N de Pennington, P Plaha, R Stacey, ... Metabolites 9 (2), 35, 2019 | 27 | 2019 |
Recent advances in molecular pathology of craniopharyngioma S Larkin, N Karavitaki F1000Research 6, 2017 | 26 | 2017 |
Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas KM Larkin SJ, Ferrau F, Karavitaki N, Hernández-Ramírez LC, Ansorge O ... European Journal of Endocrinology, 2014 | 15 | 2014 |
Endotext S Larkin, O Ansorge, KR Feingold, B Anawalt, A Boyce, G Chrousos, ... South Dartmouth (MA): MDText. com, Inc. Available from:, 2000 | 12 | 2000 |
The improved detection of 2-hydroxyglutarate in gliomas at 7T using high-bandwidth adiabatic refocusing pulses UE Emir, SJ Larkin, N de Pennington, N Voets, P Plaha, R Stacey, ... Proceedings of the 23rd Annual Meeting of ISMRM, Toronto, Canada 2236, 2013 | 2 | 2013 |
The benefits of in vivo 2-hydroxyglutarate detection using semi-LASER at 7T and 3T: a comparative study A Berrington, SJ Larkin, N de Pennington, NL Voets, P Plaha, R Stacey, ... ISMRM. Singapore, 2016 | 1 | 2016 |